I think we're really fortunate that we're in an innovation space that is not creating a new drug or a new diagnostic test because those trials can take ten years. It is almost impossible to move fast. For us, we're talking about software tweaks. So it is a week at a time. We're talking about rel...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
